Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Jan 04, 2024 | Sale | $27.55 | 35,702 | 983,504 | 20,099 | Jan 04, 2024, 05:16 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Jan 02, 2024 | Sale | $28.52 | 235,200 | 6,707,081 | 254,899 | Jan 04, 2024, 05:16 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Jan 03, 2024 | Sale | $27.79 | 199,098 | 5,532,276 | 55,801 | Jan 04, 2024, 05:16 PM | |
RPRX | Royalty Pharma plc | Giuliani Mario Germano | Director | Dec 29, 2023 | Sale | $28.04 | 65,803 | 1,845,406 | 2,477,520 | Jan 03, 2024, 04:31 PM | |
RPRX | Royalty Pharma plc | Fernandez Henry A | Director | Dec 29, 2023 | Option Exercise | $27.71 | 1,353 | 37,493 | 40,728 | Dec 29, 2023, 05:14 PM | |
RPRX | Royalty Pharma plc | Bassler Bonnie L | Director | Dec 29, 2023 | Option Exercise | $27.71 | 1,353 | 37,493 | 46,522 | Dec 29, 2023, 05:11 PM | |
RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | Dec 27, 2023 | Sale | $28.01 | 41,729 | 1,168,754 | 2,753,186 | Dec 29, 2023, 04:29 PM | |
RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | Dec 28, 2023 | Sale | $28.20 | 209,863 | 5,918,934 | 2,543,323 | Dec 29, 2023, 04:29 PM | |
RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | Dec 15, 2023 | Sale | $28.01 | 10,229 | 286,499 | 2,794,915 | Dec 19, 2023, 04:30 PM | |
RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | Dec 13, 2023 | Sale | $28.95 | 307,935 | 8,916,012 | 3,169,585 | Dec 15, 2023, 04:31 PM | |
RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | Dec 14, 2023 | Sale | $28.91 | 364,441 | 10,534,276 | 2,805,144 | Dec 15, 2023, 04:31 PM | |
RPRX | Royalty Pharma plc | Fernandez Henry A | Director | Sep 29, 2023 | Option Exercise | $27.08 | 1,384 | 37,475 | 39,375 | Oct 03, 2023, 04:25 PM | |
RPRX | Royalty Pharma plc | Bassler Bonnie L | Director | Sep 29, 2023 | Option Exercise | $27.08 | 1,384 | 37,475 | 45,169 | Oct 03, 2023, 04:23 PM | |
RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Aug 09, 2023 | Sale | $30.72 | 37,500 | 1,151,936 | 827,500 | Aug 11, 2023, 05:00 PM | |
RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Aug 10, 2023 | Sale | $30.75 | 37,500 | 1,153,091 | 790,000 | Aug 11, 2023, 05:00 PM | |
RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Jul 12, 2023 | Sale | $31.07 | 37,500 | 1,165,256 | 902,500 | Jul 14, 2023, 06:09 PM | |
RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Jul 13, 2023 | Sale | $30.93 | 37,500 | 1,159,957 | 865,000 | Jul 14, 2023, 06:09 PM | |
RPRX | Royalty Pharma plc | Fernandez Henry A | Director | Jun 30, 2023 | Option Exercise | $31.03 | 1,208 | 37,481 | 37,991 | Jun 30, 2023, 09:15 AM | |
RPRX | Royalty Pharma plc | Bassler Bonnie L | Director | Jun 30, 2023 | Option Exercise | $31.03 | 1,208 | 37,481 | 43,785 | Jun 30, 2023, 09:12 AM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | Jun 28, 2023 | Buy | $29.51 | 130,000 | 3,836,768 | 600,000 | Jun 28, 2023, 04:01 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | Jun 12, 2023 | Buy | $33.00 | 45,000 | 1,484,946 | 425,000 | Jun 13, 2023, 04:01 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | Jun 13, 2023 | Buy | $32.78 | 45,000 | 1,474,902 | 470,000 | Jun 13, 2023, 04:01 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Jun 02, 2023 | Sale | $33.54 | 1,686 | 56,542 | 128,314 | Jun 06, 2023, 05:07 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Jun 05, 2023 | Sale | $33.54 | 19,215 | 644,446 | 109,099 | Jun 06, 2023, 05:07 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Jun 06, 2023 | Sale | $33.82 | 79,099 | 2,674,796 | 30,000 | Jun 06, 2023, 05:07 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Jun 02, 2023 | Sale | $33.65 | 92,221 | 3,102,803 | 120,000 | Jun 06, 2023, 05:07 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | May 24, 2023 | Buy | $32.25 | 150,000 | 4,837,440 | 380,000 | May 24, 2023, 06:45 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | May 22, 2023 | Sale | $32.82 | 1,750,000 | 57,434,999 | 6,762 | May 22, 2023, 08:36 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | May 16, 2023 | Buy | $33.57 | 160,388 | 5,383,728 | 160,388 | May 17, 2023, 06:41 PM | |
RPRX | Royalty Pharma plc | Legorreta Pablo G. | CEO, Chairman of the Board | May 17, 2023 | Buy | $32.94 | 69,612 | 2,293,096 | 230,000 | May 17, 2023, 06:41 PM | |
RPRX | Royalty Pharma plc | Fernandez Henry A | Director | Mar 31, 2023 | Option Exercise | $35.73 | 1,049 | 37,478 | 29,036 | Mar 31, 2023, 04:40 PM | |
RPRX | Royalty Pharma plc | Bassler Bonnie L | Director | Mar 31, 2023 | Option Exercise | $35.73 | 1,049 | 37,478 | 34,830 | Mar 31, 2023, 04:38 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Mar 29, 2023 | Sale | $36.95 | 9,926 | 366,766 | 1,586,786 | Mar 30, 2023, 05:53 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Mar 30, 2023 | Sale | $36.26 | 130,024 | 4,714,345 | 1,456,762 | Mar 30, 2023, 05:53 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Mar 28, 2023 | Sale | $37.06 | 100,000 | 3,706,130 | 225,000 | Mar 30, 2023, 05:52 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Mar 29, 2023 | Sale | $37.03 | 12,779 | 473,165 | 212,221 | Mar 30, 2023, 05:52 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Feb 23, 2023 | Sale | $37.27 | 25,000 | 931,658 | 325,000 | Feb 27, 2023, 07:14 PM | |
RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Feb 22, 2023 | Sale | $37.30 | 23,333 | 870,239 | 46,667 | Feb 24, 2023, 06:26 PM | |
RPRX | Royalty Pharma plc | Fernandez Henry A | Director | Dec 30, 2022 | Option Exercise | $39.76 | 943 | 37,495 | 27,987 | Jan 03, 2023, 05:11 PM | |
RPRX | Royalty Pharma plc | Bassler Bonnie L | Director | Dec 30, 2022 | Option Exercise | $39.76 | 943 | 37,495 | 33,781 | Jan 03, 2023, 05:09 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Dec 09, 2022 | Sale | $42.07 | 19,990 | 840,939 | 136,722 | Dec 13, 2022, 06:20 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Dec 12, 2002 | Sale | $41.98 | 40,010 | 1,679,684 | 96,712 | Dec 13, 2022, 06:20 PM | |
RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | Dec 05, 2022 | Sale | $43.15 | 84,302 | 3,637,463 | 7,795,072 | Dec 07, 2022, 04:30 PM | |
RPRX | Royalty Pharma plc | MGG Strategic SICAF SIF S.A. - MGG Strategic | 10% Owner | Dec 01, 2022 | Sale | $44.10 | 165,000 | 7,277,325 | 22,225,000 | Dec 05, 2022, 04:44 PM | |
RPRX | Royalty Pharma plc | Skyeline Management Ltd | 10% Owner | Dec 02, 2022 | Sale | $43.98 | 197,766 | 8,697,412 | 7,879,374 | Dec 05, 2022, 04:44 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Nov 22, 2022 | Sale | $43.14 | 1,900 | 81,969 | 350,000 | Nov 22, 2022, 05:29 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Nov 22, 2022 | Sale | $43.19 | 14,469 | 624,879 | 130,000 | Nov 22, 2022, 05:29 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Nov 21, 2022 | Sale | $43.11 | 3,100 | 133,638 | 351,900 | Nov 22, 2022, 05:29 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Nov 21, 2022 | Sale | $43.11 | 20,531 | 885,081 | 144,469 | Nov 22, 2022, 05:29 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Nov 17, 2022 | Sale | $42.33 | 120,000 | 5,079,924 | 156,712 | Nov 21, 2022, 06:12 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Nov 10, 2022 | Sale | $43.85 | 25,000 | 1,096,288 | 355,000 | Nov 14, 2022, 05:13 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & CLO | Nov 10, 2022 | Sale | $43.85 | 25,000 | 1,096,325 | 165,000 | Nov 14, 2022, 05:13 PM | |
RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Nov 08, 2022 | Sale | $43.47 | 24,500 | 1,065,013 | 940,000 | Nov 10, 2022, 05:04 PM | |
RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Nov 02, 2022 | Sale | $43.06 | 5,500 | 236,846 | 964,500 | Nov 04, 2022, 07:16 PM | |
RPRX | Royalty Pharma plc | Bassler Bonnie L | Director | Sep 30, 2022 | Option Exercise | $41.06 | 913 | 37,490 | 32,838 | Sep 30, 2022, 04:29 PM | |
RPRX | Royalty Pharma plc | Fernandez Henry A | Director | Sep 30, 2022 | Option Exercise | $41.06 | 913 | 37,490 | 27,044 | Sep 30, 2022, 04:25 PM | |
RPRX | Royalty Pharma plc | Reddoch James F. | EVP & Chief Scientific Officer | Sep 28, 2022 | Sale | $41.23 | 100,000 | 4,122,670 | 820,800 | Sep 30, 2022, 04:23 PM | |
RPRX | Royalty Pharma plc | Skyeline Management Ltd | 10% Owner | Sep 28, 2022 | Sale | $41.05 | 32,593 | 1,337,943 | 8,077,140 | Sep 30, 2022, 04:15 PM | |
RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | Sep 22, 2022 | Sale | $41.17 | 211,380 | 8,702,113 | 8,109,733 | Sep 26, 2022, 04:30 PM | |
RPRX | Royalty Pharma plc | MGG Strategic SICAF SIF S.A. | 10% Owner | Sep 20, 2022 | Sale | $41.02 | 398,145 | 16,331,175 | 22,390,000 | Sep 22, 2022, 04:31 PM | |
RPRX | Royalty Pharma plc | Skyeline Management Ltd | 10% Owner | Sep 21, 2022 | Sale | $41.25 | 125,697 | 5,185,378 | 8,321,113 | Sep 22, 2022, 04:31 PM | |
RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. - GG Strategic | 10% Owner | Sep 20, 2022 | Sale | $41.02 | 267,815 | 10,985,798 | 21,426,170 | Sep 22, 2022, 04:30 PM | |
RPRX | Royalty Pharma plc | MGG Strategic SICAF SIF S.A. - MGG Strategic | 10% Owner | Sep 16, 2022 | Sale | $41.72 | 154,986 | 6,466,140 | 22,890,000 | Sep 20, 2022, 04:30 PM | |
RPRX | Royalty Pharma plc | MGG Strategic SICAF SIF S.A. | 10% Owner | Sep 19, 2022 | Sale | $41.50 | 232,185 | 9,635,678 | 22,657,815 | Sep 20, 2022, 04:30 PM | |
RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. - GG Strategic | 10% Owner | Sep 16, 2022 | Sale | $41.72 | 154,986 | 6,466,279 | 21,926,170 | Sep 20, 2022, 04:30 PM | |
RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. - GG Strategic | 10% Owner | Sep 19, 2022 | Sale | $41.50 | 232,185 | 9,635,654 | 21,693,985 | Sep 20, 2022, 04:30 PM | |
RPRX | Royalty Pharma plc | MGG Strategic SICAF SIF S.A. - MGG Strategic | 10% Owner | Sep 15, 2022 | Sale | $42.26 | 154,154 | 6,514,887 | 23,044,986 | Sep 16, 2022, 05:09 PM | |
RPRX | Royalty Pharma plc | MGG Strategic SICAF SIF S.A. | 10% Owner | Sep 14, 2022 | Sale | $42.48 | 190,860 | 8,108,039 | 23,199,140 | Sep 16, 2022, 05:09 PM | |
RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. - GG Strategic | 10% Owner | Sep 14, 2022 | Sale | $42.48 | 190,860 | 8,108,134 | 22,235,310 | Sep 16, 2022, 05:05 PM | |
RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. - GG Strategic | 10% Owner | Sep 15, 2022 | Sale | $42.26 | 154,154 | 6,514,918 | 22,081,156 | Sep 16, 2022, 05:05 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Sep 14, 2022 | Sale | $42.41 | 47,975 | 2,034,428 | 328,737 | Sep 15, 2022, 07:56 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Sep 15, 2022 | Sale | $42.21 | 52,025 | 2,195,960 | 276,712 | Sep 15, 2022, 07:56 PM | |
RPRX | Royalty Pharma plc | Skyeline Management Ltd | 10% Owner | Sep 08, 2022 | Sale | $42.74 | 237,619 | 10,155,598 | 8,577,140 | Sep 09, 2022, 04:18 PM | |
RPRX | Royalty Pharma plc | Avara Management Ltd | 10% Owner | Sep 07, 2022 | Sale | $42.66 | 261,881 | 11,171,739 | 8,814,759 | Sep 09, 2022, 04:18 PM | |
RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. - GG Strategic | 10% Owner | Sep 07, 2022 | Sale | $42.53 | 250,000 | 10,632,575 | 22,674,176 | Sep 09, 2022, 04:17 PM | |
RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. - GG Strategic | 10% Owner | Sep 08, 2022 | Sale | $42.86 | 248,006 | 10,629,958 | 22,426,170 | Sep 09, 2022, 04:17 PM | |
RPRX | Royalty Pharma plc | GG 1978 SICAF SIF S.A. - GG Strategic | 10% Owner | Aug 25, 2022 | Sale | $44.00 | 1,994 | 87,736 | 22,924,176 | Aug 29, 2022, 05:41 PM | |
RPRX | Royalty Pharma plc | Skyeline Management Ltd | 10% Owner | Aug 25, 2022 | Sale | $44.00 | 500 | 22,000 | 9,076,640 | Aug 29, 2022, 05:40 PM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Aug 09, 2022 | Sale | $43.73 | 45,000 | 1,967,823 | 376,712 | Aug 11, 2022, 05:07 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | Aug 09, 2022 | Sale | $43.92 | 11,859 | 520,801 | 210,109 | Aug 11, 2022, 05:02 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | Aug 10, 2022 | Sale | $43.93 | 8,995 | 395,108 | 201,114 | Aug 11, 2022, 05:02 PM | |
RPRX | Royalty Pharma plc | Coyne Terrance P. | EVP & CFO | Aug 01, 2022 | Sale | $43.19 | 30,000 | 1,295,727 | 970,000 | Aug 03, 2022, 07:12 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | Jul 28, 2022 | Sale | $43.97 | 4,046 | 177,893 | 221,968 | Aug 01, 2022, 05:01 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | Jul 25, 2022 | Sale | $42.90 | 19,557 | 839,066 | 410,443 | Jul 27, 2022, 06:20 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | Jul 25, 2022 | Sale | $42.98 | 11,114 | 477,642 | 228,886 | Jul 27, 2022, 06:20 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | Jul 26, 2022 | Sale | $43.03 | 5,443 | 234,223 | 405,000 | Jul 27, 2022, 06:20 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | Jul 26, 2022 | Sale | $43.12 | 13,886 | 598,824 | 226,114 | Jul 27, 2022, 06:20 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | Jul 27, 2022 | Sale | $43.76 | 25,000 | 1,094,055 | 380,000 | Jul 27, 2022, 06:20 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | Jul 27, 2022 | Sale | $43.90 | 100 | 4,390 | 226,014 | Jul 27, 2022, 06:20 PM | |
RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Jul 25, 2022 | Sale | $43.05 | 3,600 | 154,985 | 19,734 | Jul 27, 2022, 06:17 PM | |
RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Jul 26, 2022 | Sale | $43.20 | 19,734 | 852,461 | 0 | Jul 27, 2022, 06:17 PM | |
RPRX | Royalty Pharma plc | Bassler Bonnie L | Director | Jun 30, 2022 | Option Exercise | $41.52 | 903 | 37,493 | 31,925 | Jun 30, 2022, 06:55 AM | |
RPRX | Royalty Pharma plc | Fernandez Henry A | Director | Jun 30, 2022 | Option Exercise | $41.52 | 903 | 37,493 | 26,131 | Jun 30, 2022, 06:51 AM | |
RPRX | Royalty Pharma plc | RIGGS RORY B | Director | Jun 29, 2022 | Sale | $42.17 | 30,000 | 1,265,238 | 421,712 | Jun 29, 2022, 06:02 PM | |
RPRX | Royalty Pharma plc | Urist Marshall | EVP, Research & Investments | Jun 24, 2022 | Sale | $43.19 | 23,333 | 1,007,694 | 23,334 | Jun 24, 2022, 05:19 PM | |
RPRX | Royalty Pharma plc | Reddoch James F. | EVP & Chief Scientific Officer | Jun 08, 2022 | Sale | $41.56 | 100,000 | 4,155,900 | 920,800 | Jun 10, 2022, 05:13 PM | |
RPRX | Royalty Pharma plc | Reddoch James F. | EVP & Chief Scientific Officer | May 27, 2022 | Sale | $41.08 | 75,000 | 3,081,008 | 1,020,800 | May 31, 2022, 05:23 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | May 26, 2022 | Sale | $40.21 | 86,026 | 3,459,338 | 443,974 | May 31, 2022, 05:19 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | May 27, 2022 | Sale | $40.77 | 13,974 | 569,754 | 430,000 | May 31, 2022, 05:19 PM | |
RPRX | Royalty Pharma plc | Lloyd George W. | EVP, Investments & GC | May 23, 2022 | Sale | $40.27 | 100,000 | 4,026,770 | 530,000 | May 25, 2022, 05:10 PM |